These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22174294)

  • 21. Using the phenoscape knowledgebase to relate genetic perturbations to phenotypic evolution.
    Manda P; Balhoff JP; Lapp H; Mabee P; Vision TJ
    Genesis; 2015 Aug; 53(8):561-71. PubMed ID: 26220875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of global resources for human genetic variation and disease.
    Schofield PN; Hancock JM
    Hum Mutat; 2012 May; 33(5):813-6. PubMed ID: 22415892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PharmGKB: the Pharmacogenomics Knowledge Base.
    Thorn CF; Klein TE; Altman RB
    Methods Mol Biol; 2013; 1015():311-20. PubMed ID: 23824865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A SNPshot of PubMed to associate genetic variants with drugs, diseases, and adverse reactions.
    Hakenberg J; Voronov D; Nguyên VH; Liang S; Anwar S; Lumpkin B; Leaman R; Tari L; Baral C
    J Biomed Inform; 2012 Oct; 45(5):842-50. PubMed ID: 22564364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating VA's NDF-RT drug terminology with PharmGKB: preliminary results.
    Pathak J; Weiss LC; Durski MJ; Zhu Q; Freimuth RR; Chute CG
    Pac Symp Biocomput; 2012; ():400-9. PubMed ID: 22174295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using PharmGKB to train text mining approaches for identifying potential gene targets for pharmacogenomic studies.
    Pakhomov S; McInnes BT; Lamba J; Liu Y; Melton GB; Ghodke Y; Bhise N; Lamba V; Birnbaum AK
    J Biomed Inform; 2012 Oct; 45(5):862-9. PubMed ID: 22564551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranking gene-drug relationships in biomedical literature using Latent Dirichlet Allocation.
    Wu Y; Liu M; Zheng WJ; Zhao Z; Xu H
    Pac Symp Biocomput; 2012; ():422-33. PubMed ID: 22174297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The integration of personalized and systems medicine: bioinformatics support for pharmacogenomics and drug discovery.
    Yan Q
    Methods Mol Biol; 2008; 448():1-19. PubMed ID: 18370227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Similarity-based search of model organism, disease and drug effect phenotypes.
    Hoehndorf R; Gruenberger M; Gkoutos GV; Schofield PN
    J Biomed Semantics; 2015; 6():6. PubMed ID: 25763178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automating data acquisition into ontologies from pharmacogenetics relational data sources using declarative object definitions and XML.
    Rubin DL; Hewett M; Oliver DE; Klein TE; Altman RB
    Pac Symp Biocomput; 2002; ():88-99. PubMed ID: 11928521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotype mining for functional genomics and gene discovery.
    Groth P; Leser U; Weiss B
    Methods Mol Biol; 2011; 760():159-73. PubMed ID: 21779996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An integrative, translational approach to understanding rare and orphan genetically based diseases.
    Hoehndorf R; Schofield PN; Gkoutos GV
    Interface Focus; 2013 Apr; 3(2):20120055. PubMed ID: 23853703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug repurposing and adverse event prediction using high-throughput literature analysis.
    Deftereos SN; Andronis C; Friedla EJ; Persidis A; Persidis A
    Wiley Interdiscip Rev Syst Biol Med; 2011; 3(3):323-34. PubMed ID: 21416632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenome-driven disease genetics prediction toward drug discovery.
    Chen Y; Li L; Zhang GQ; Xu R
    Bioinformatics; 2015 Jun; 31(12):i276-83. PubMed ID: 26072493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From phenotype to gene: detecting disease-specific gene functional modules via a text-based human disease phenotype network construction.
    Zhang S; Wu C; Li X; Chen X; Jiang W; Gong BS; Li J; Yan YQ
    FEBS Lett; 2010 Aug; 584(16):3635-43. PubMed ID: 20659468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB).
    Owen RP; Klein TE; Altman RB
    Clin Pharmacol Ther; 2007 Oct; 82(4):472-5. PubMed ID: 17713470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ontology development for a pharmacogenetics knowledge base.
    Oliver DE; Rubin DL; Stuart JM; Hewett M; Klein TE; Altman RB
    Pac Symp Biocomput; 2002; ():65-76. PubMed ID: 11928517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RAMEDIS: a comprehensive information system for variations and corresponding phenotypes of rare metabolic diseases.
    Töpel T; Scheible D; Trefz F; Hofestädt R
    Hum Mutat; 2010 Jan; 31(1):E1081-8. PubMed ID: 19953641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PharmGKB: a logical home for knowledge relating genotype to drug response phenotype.
    Altman RB
    Nat Genet; 2007 Apr; 39(4):426. PubMed ID: 17392795
    [No Abstract]   [Full Text] [Related]  

  • 40. Unraveling dynamic activities of autocrine pathways that control drug-response transcriptome networks.
    Tamada Y; Araki H; Imoto S; Nagasaki M; Doi A; Nakanishi Y; Tomiyasu Y; Yasuda K; Dunmore B; Sanders D; Humphreys S; Print C; Charnock-Jones DS; Tashiro K; Kuhara S; Miyano S
    Pac Symp Biocomput; 2009; ():251-63. PubMed ID: 19209706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.